Wntrix, Inc.

Bellaire, TX

UEI
HE6LHLBVCLY5
CAGE
7BQ98
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
4412 Jim West St, Bellaire, TX 77401, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of drug conjugates of r-spondin peptibodies for the treatment of colorectal cancer R41CA281553 National Cancer Institute (NIH) $400,000
Investigation of antibody-drug conjugates of a novel target R41CA213479 National Cancer Institute (NIH) $225,000

Quick answers

Is Wntrix, Inc. registered in SAM.gov?

Yes. Wntrix, Inc.'s SAM.gov registration is active through May 21, 2027.

What is Wntrix, Inc.'s most recent federal award?

Wntrix, Inc.'s most recent federal grant award is Development of drug conjugates of r-spondin peptibodies for the treatment of colorectal cancer (R41CA281553), from National Cancer Institute (NIH), on May 1, 2023.

On GovTribe

See Wntrix, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login